Bausch + Lomb Corporation Logo

Bausch + Lomb Corporation (S2L)

FSX

Currency in EUR
14.70
+0.20 (+1.38%)

Closed

Aug 25, 2026

Day's Range

14.60
14.70

52 wk Range

12.00
15.70

Overview - S2L - Bausch + Lomb Corporation

Key Statistics

Valuation

Enterprise Value

8.53B

P/E (Trailing)

‪-14.21‬

PEG Ratio

‪0.18‬

Price / Sales (TTM)

‪0.97‬

Price / Book

‪0.92‬

EV / EBITDA

‪12.24‬

Profitability

Gross Margin

‪62.19%‬

Profit Margin

‪-3.21%‬

Operating Margin

‪7.74%‬

Return on Assets

‪1.82%‬

Return on Equity

‪-2.51%‬

Ownership

Shares Outstanding

357.05M

Float

45.30M

Held by Insiders

‪87.34%‬

Held by Institutions

‪11.14%‬

Price stats

Beta

‪0.55‬

50-Day Avg

‪14.18‬

200-Day Avg

‪14.00‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - S2L - Bausch + Lomb Corporation

Peers - S2L - Bausch + Lomb Corporation

Peer Comparison

Compared with companies in Medical Instruments & Supplies listed on FSX.

Profile Summary - S2L - Bausch + Lomb Corporation

About

Bausch + Lomb Corporation, a leading health care company, primarily focuses on eye health products. The corporation specializes in the development, manufacture, and marketing of a comprehensive range of contact lenses, lens care products, ophthalmic pharmaceuticals, and surgical devices, all designed to improve sight…

SectorHealthcare
IndustryMedical Instruments & Supplies
Employees13.50K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.